dr. jhaveri on the use of trastuzumab biosimilars in breast cancer
Published 4 years ago • 510 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
0:56
dr. jhaveri discusses the utility of t-dm1 in the neoadjuvant setting
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
1:47
the use of trastuzumab and biosimilars in the treatment of breast cancer
-
3:38
biosimilar trastuzumab
-
1:12
dr. esteva on trastuzumab biosimilar in breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:13
dr. jhaveri on acquired resistance to cdk 4/6 inhibitors in breast cancer
-
2:53
the extensive treatment story: navigating complexities, the many faces of cancer treatment- part b
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
1:49
dr. esteva on trastuzumab biosimilar in patients with her2 breast cancer
-
12:12
breast cancer treatment - trastuzumab biosimilars
-
2:09
dr. esteva on the future of biosimilars in breast cancer
-
1:11
dr. hurvitz on importance of biosimilars in her2 breast cancer
-
0:59
dr. hope rugo on safety of trastuzumab biosimilar for her2 breast cancer
-
1:41
dr. pegram on the development of trastuzumab biosimilars
-
1:00
dr. dang on the significance of the myl-1401o biosimilar in her2-positive metastatic breast cancer
-
1:43
dr. rugo discusses the equivalency of trastuzumab biosimilars
-
1:55
dr. kolberg on collecting real-world biosimilar trastuzumab data in breast cancer
-
1:05
biosimilar trastuzumab: a cost effective alternative for breast cancer treatment